Screening compound: C21H26N4O5 (P392-2032)

Screening compound: C<sub>21</sub>H<sub>26</sub>N<sub>4</sub>O<sub>5</sub> (P392-2032)
Screening compound: C<sub>21</sub>H<sub>26</sub>N<sub>4</sub>O<sub>5</sub> (P392-2032) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C21H26N4O5 (P392-2032)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P392-2032

Molecular Formula

C21H26N4O5 (C21 H26 N4 O5)

Compound Name

2-({1-[(3,4-dimethoxyphenyl)carbamoyl]pyrrolidin-3-yl}oxy)-N,N-dimethylpyridine-3-carboxamide

IUPAC name

2-({1-[(34-dimethoxyphenyl)carbamoyl]pyrrolidin-3-yl}oxy)-NN-dimethylpyridine-3-carboxamide

SMILES

CN(C)C(c1cccnc1OC(CC1)CN1C(Nc(cc1)cc(OC)c1OC)=O)=O

InChI

InChI=1S/C21H26N4O5/c1-24(2)20(26)16-6-5-10-22-19(16)30-15-9-11-25(13-15)21(27)23-14-7-8-17(28-3)18(12-14)29-4/h5-8,10,12,15H,9,11,13H2,1-4H3,(H,23,27)/t15-/m1/s1

InChI Key

RBUJDIGXGNNWFX-OAHLLOKOSA-N

MDL Number (MFCD)

MFCD28999177

C21H26N4O5 (P392-2032) in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

CNS Targets (44014 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Nervous system
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Targets:
  • Ion Channels
  • Kinases
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C21H26N4O5 (P392-2032) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C21H26N4O5 (P392-2032)?
Check Price and Availability of C21H26N4O5 (P392-2032), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C21H26N4O5 (P392-2032) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C21H26N4O5 (P392-2032)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C21H26N4O5 (P392-2032)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C21H26N4O5 (P392-2032) available by request